• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Celera Genomics of Rockville Begins Phase 1 Clinical Trial for Psoriasis Drug

Posted on: Wednesday, 21 September 2005, 21:00 CDT

Celera Genomics, of Rockville, a drug discovery company principally focused on cancer, autoimmune and inflammatory diseases, announced the initiation of a Phase 1 clinical trial for CRA- 028129, an experimental drug for the treatment of psoriasis, a chronic skin condition

. The study is being conducted at the Christchurch Clinical Studies Trust in Christchurch, New Zealand.

Source: The Daily Record (Baltimore)

More News in this Category